Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple inhaled drug during surgery prevent dangerous lung complications?

NCT ID NCT07000760

Disease control Sponsor: Jun Zhang Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether giving lidocaine as a mist into the lungs during major abdominal surgery could lower the chance of serious lung problems after the operation. Lung complications after surgery can lengthen hospital stays and increase costs and death risk. The study included 270 adults having planned major non-cardiac surgery under general anesthesia. The key approach was to use lidocaine's anti-inflammatory effects to protect the lungs.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

270 people

The number who actually took part.

Started

Jun 2025

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients who have signed the informed consent form and are willing to complete the study according to the protocol * Age ≥18 years old and ≤90 years old * ASA classification grades I-III * Elective major non-cardiac surgery * General anesthesia under tracheal intubation * Monitor invasive arterial blood pressure * The expected operation time ≥2 hours Exclusion Criteria: * Untreated ischemic heart disease Severe cardiovascular and cerebrovascular diseases * Severe asthma, pulmonary bullae, pneumothorax, bronchopleural fistula, etc * Severe underlying liver and kidney diseases * Age under 18 years old or over 90 years old * The expected operation time is ≥2 hours

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Postoperative pulmonary complications (PPCS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Postoperative pulmonary complications (PPCS)

Contacts and locations

Locations

  • Fudan University Shanghai Cancer Center

    Shanghai, China

  • Fudan University Shanghai Cancer Centre

    Shanghai, Shanghai Municipality, 200032, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.